Oral Abstract Session:
275. Featured Oral Abstract
Saturday, October 6, 2018: 4:05 PM-4:20 PM
Room: N Hall D

Tracks: HIV-STD-TB, Adult ID, Epidemiology and Infection Control, Trainee, Global ID, Investigative ID, Pediatric ID, Transplant ID


Moderator:  Rachel Miller, MD, Duke University Medical Center

Presentations:
4:05 PM
Preemptive therapy (PET) versus prophylaxis for prevention of cytomegalovirus (CMV) disease in high-risk donor seropositive/recipient seronegative (D+R-) liver transplant recipients (LTR): A NIH-sponsored, randomized, controlled, multicenter trial
Nina Singh, M.D.; Drew Winston, M.D.; Raymund R. Razonable, MD, FIDSA; G. Marshall Lyon III, MD; Fernanda P. Silveira, MD, MS; Marilyn Wagener, MPH; Ajit P. Limaye, MD, FIDSA

CME Credits: Maximum of 0.00 hours of AMA PRA Category 1 Credit™


See more of: Oral Abstract Session

Findings in the abstracts are embargoed until 12:01 a.m. PDT, Wednesday Oct. 3rd with the exception of research findings presented at the IDWeek press conferences.